Feature | Coronavirus (COVID-19) | January 19, 2022 | By Avielle Siegel, Paul J. Chang, David M. Paushter, et al.

ITN's new feature, Clinical Case of the Month, features images and clinical case studies from your medical imaging colleagues

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath.

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath.


A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath. The patient was diaphoretic and retching on arrival. Physical examination showed diffuse abdominal tenderness, mild tachypnea and tachycardia.

Imaging Findings

A computed tomography (CT) scan of the abdomen and pelvis revealed imaging findings in the lung bases of peripheral nodular airspace and ground-glass opacities. Abdominal imaging findings showed hepatosplenomegaly and severe hepatic steatosis; no abnormalities in the gastrointestinal tract, mesentery or vasculature; and no lymphadenopathy or ascites. 

Diagnosis: Coronavirus Disease (COVID-19)

Subsequent CT chest and SARS-CoV-2 PCR testing confirmed the diagnosis of COVID-19. The patient was admitted to the hospital with a primary diagnosis of diabetic ketoacidosis, the likely cause of his abdominal pain, secondary to SARS-CoV-2 infection. The patient was discharged home 9 days later. 

Further Reading

Information for this case study was provided by the American Roentgen Ray Society (ARRS). Learn more by reading the open-access AJR article “Lung Base Findings of Coronavirus Disease (COVID-19) on Abdominal CT in Patients With Predominant Gastrointestinal Symptoms,” as well as “Unexpected Findings of Coronavirus Disease (COVID-19) at the Lung Bases on Abdominopelvic CT.” 

Call for Entries

Do you have a clinical case you’d like to share with ITN's audience? If so, please send high-resolution images and a brief written case study to [email protected]

Related COVID-19 imaging


Related Content

News | Artificial Intelligence

Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how ...

Time September 12, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
News | Computed Tomography (CT)

SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...

Time August 06, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now